Immunotherapy, or the ability to use a person’s own immune system to fight cancer, is rising as a promising treatment option in cancer care. In our first episode of our Cancer HealthCasts miniseries, we talk to one of the fathers of successful immunotherapy, Dr. Steven Rosenberg, about how a study he’s leading is unveiling a new form of personalized immunotherapy using tumor-infiltrating lymphocytes to combat metastatic breast cancer.
Cancer HealthCast
34m listen
How Personalized Immunotherapy Can Help Combat Metastatic Breast Cancer
A recent NCI study explores new immunotherapy treatment for metastatic breast cancer.
-
Dr. Steven Rosenberg Surgery Branch Chief, Center for Cancer Research NCI
Related Content
-
Building Better Data Governance Across FDA
The agency is using emerging technology to tackle its data challenges.
19m listen -
Coast Guard Poised for Growth in Cyber
The service’s prevention policy chief discusses his priorities for combatting cyber incidents that could have global impacts.
23m listen -
How VA is Using Digital Services to Expand Care to Veterans
CIO Kurt DelBene says the the agency’s 2024 priorities included AI adoption, hiring and a better user experience for veterans.
30m listen -
Cancer HealthCast: This Unique Network Closes Research Gaps in Cancer Genomics
In this episode, Dr. Leah Mechanic, Program Director at NCI and Dr. Bettina Drake, Professor at Washington University School of Medicine
24m listen
